Ísrael - hebreska - Ministry of Health

teva pharmaceutical industries ltd, israel - oxolamine citrate - סירופ - oxolamine citrate 1 g / 100 ml - oxolamine - oxolamine - acute and chronic infections of respiratory tract with cough: bronchitis, tracheitis, laryngotracheitis, spastic bronchitis, pertusis, smoker's cough and cough complicating the common cold.

Ísrael - hebreska - Ministry of Health

teva pharmaceutical industries ltd, israel - oxolamine citrate - סירופ - oxolamine citrate 10 mg/ml - oxolamine - oxolamine - cough suppressant.

Ísrael - hebreska - Ministry of Health

biovac ltd., israel - florfenicol - תמיסה - florfenicol 10 %w/v - treatment of bacterial infections susceptible to florfenicol in chickens

Ísrael - hebreska - Ministry of Health

rafa laboratories ltd - budesonide - budesonide 9 mg - budesonide

Ísrael - hebreska - Ministry of Health

rafa laboratories ltd - budesonide - budesonide 9 mg - budesonide

Ísrael - hebreska - Ministry of Health

rafa laboratories ltd - budesonide - budesonide 9 mg - budesonide

Ísrael - hebreska - Ministry of Health

biovac ltd., israel - sulphamethoxazole; trimethoprim - תמיסה - sulphamethoxazole 10 %w/v; trimethoprim 2.0 %w/v

Ísrael - hebreska - Ministry of Health

vitamed pharmaceutical industries ltd - bromhexine hydrochloride - תמיסה - bromhexine hydrochloride 2 mg/ml - bromhexine

Ísrael - hebreska - Ministry of Health

bristol - myers squibb, israel - atazanavir as sulfate - קפסולות - atazanavir as sulfate 300 mg - atazanavir

Ísrael - hebreska - Ministry of Health

rafa laboratories ltd - lansoprazole - קפסולות - lansoprazole 30 mg - lansoprazole - lansoprazole - for the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. healing, long- term treatment and maintenance therapy for patients with gastro-oesophageal reflux disease (gerd) or duodenal ulcer. prevention of relapse in patients with gerd or duodenal ulcer. eradication of h. pylori from the upper gastrointestinal tract in patients ,with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). short- term- treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. long-term management of pathological hypersecretory conditions including zollinger ellison syndrome. treatment and prophylaxis of nsaid- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued nsaid treatment.